Serum hepatocyte growth factor/scatter factor levels in small cell lung cancer patients

Lung Cancer

Volumn 17, Issue 2-3, 1997, Pages 211-218

  Takigawa, Nagio ^a   Segawa, Yoshihiko ^a   Maeda, Yoshinobu ^a   Takata, Ichiro ^a   Fujimoto, Nobukazu ^a  

^a NATIONAL HOSPITAL ORGANIZATION SHIKOKU CANCER CENTER   (Japan)

Author keywords

Bacterial pneumonia; Carcinoembryonic antigen; Enzyme linked immunosorbent assay; Hepatocyte growth factor scatter factor; Small cell lung cancer; Tumor marker

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; SCATTER FACTOR; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER STAGING; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LUNG SMALL CELL CANCER; LUNG TUMOR; MALE; PNEUMONIA; PRIORITY JOURNAL; TUMOR VOLUME;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CARCINOEMBRYONIC ANTIGEN; CARCINOMA, SMALL CELL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; L-LACTATE DEHYDROGENASE; LUNG DISEASES; LUNG NEOPLASMS; MALE; MIDDLE AGED; PHOSPHOPYRUVATE HYDRATASE; SENSITIVITY AND SPECIFICITY; SEX FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0030844390     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(97)00651-X     Document Type: Article

References (26)

1. Abrams J, Doyle LA, Aisner J. Staging, prognostic factors, and special considerations in small cell lung cancer. Semin Oncol 1988; 15: 261-267.
2. Bottaro DP, Rubin JS, Faletto DL, Chan AM-L, Kmiecik TE, Vande Woude GF, Aaronson SA. Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251, 802-804.
3. Defiances MC, Wolf HK, Michalopoulos GK, Zarnegar R. The presence of hepatocyte growth factor in the developing rat. Development 1992; 116: 387-395.
4. Eagles G, Warn A, Ball RY, Baillie-Johnson H, Arakaki N, Daikuhara Y, Warn RM. Hepatocyte growth factor scatter factor is present in most pleural effusion fluids from cancer patients. Br J Cancer 1996; 73, 377-381.
5. Jaques G, Bepler G, Holle R, Wolf M, Hannich T, Gropp C, Havemann K. Prognostic value of pretreatment carcinoembryonic antigen, neuron-specific enolase, and creatine kinase-BB levels in sera of patients with small cell lung cancer. Cancer 1988; 62: 125-134.
6. Lokish JJ. Plasma CEA levels in small cell lung cancer. Cancer 1982; 50, 2154-2156.
7. Maeda J, Ueki N, Hada T, Higashino K. Elevated serum hepatocyte growth factor/scatter factor levels in inflammatory lung disease. Am J Respir Crit Care Med 1995; 152, 1587-1591.
8. Matsumoto K, Date K, Ohmichi H, Nakamura T. Hepatocyte growth factor in lung morphogenesis and tumor invasion: role as a mediator in epithelium-mesenchyme and tumor-stroma interactions. Cancer Chemother Pharmacol 1996; 38: 42-47.
9. Matsumoto K, Tajima H, Hanamoue M, Kohno S, Kinoshita T, Nakamura T. Identification and characterization of 'injurin', an inducer of expression of the gene for hepatocyte growth factor. Proc Natl Acad Sci USA 1992; 89: 3800-3804.
10. Metz CE, Chen JH, Herman BA. New methods for estimating a binormal ROC curve from continuously-distributed test results. Invited for presentation at the 1990 Joint Statistical Meetings of the American Statistical Society and the Biometric Society, Anaheim, CA, August.
11. Nakamura T, Nawa K, Ichihara A. Partial purification and characterization of hepatocyte growth factor from serum of hepatectomized rats. Biochem Biophys Res Commun 1984; 122: 1450-1459.
12. Naldini L, Vigna E, Narsimhan RP, Gaudino G, Zarnegar R, Michalopoulos GK, Comoglio PM. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET. Oncogene 1991; 6: 501-504.
13. Rosen EM, Zitnik RJ, Ellias JA, Bhargava MM, Wines J, Goldberg ID. The interaction of HGF-SF with other cytokines in tumor invasion and angiogenesis. In: Goldberg ID, Rosen EM, editors. Hepatocyte Growth Factor-Scatter Factor (HGF-SF) and the C-Met Receptor. Basal, Switzerland: Birkhaüser Verlag EXL, 1993; 65: 301-310.
14. Rygaard K, Klausen B, Nakamura T, Spong-Thomsen M. Growth inhibition and change in morphology and motility of SCLC lines by hepatocyte growth factor/scatter factor. J Oncol 1993; 6, 501-504.
15. Rygaard K, Nakamura T, Spang-Thomsen M. Expression of the proto-oncogenes c-met and c-kit and their ligands, hepatocyte growth factor/scatter factor and stem cell factor, in SCLC cell lines and xenografts. Br J Cancer 1993; 67: 37-46.
16. Stoker M, Gherardi E, Perryman M, Gray J. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987; 327: 239-242.
17. Stoker M, Perryman M. An epithelial scatter factor released by embryo fibroblasts. J Cell Sci 1985; 77: 209-233.
18. Sugimura K, Kim T, Goto T, Kasai S, Takemoto Y, Matsuda J, Yoshimoto M, Yamagami S, Kishimoto T. Serum hepatocyte growth factor levels in patients with chronic renal failure. Nephron 1995; 70: 324-328.
19. Takada M, Kusunoki Y, Masuda N, Matui K, Yana T, Ushijima S, Iida K, Tamura K, Komiya T, Kawase I, Kikui N, Morino H, Fukuoka M. Pro-gastrin-releasing peptide (31-98) as a tumour marker of small-cell lung cancer: comparative evaluation with neuron-specific enolase. Br J Cancer 1996; 73: 1227-1232.
20. Taniguchi T, Toi M, Inaba K, Imazawa T, Yamamoto Y, Tominaga T. Serum concentrations of hepatocyte growth factor in breast cancer patients. Clin Cancer Res 1995; 1, 1031-1034.
21. Taniguchi T, Toi M, Tominaga T. Increase in the circulating level of hepatocyte growth factor in breast cancer patients with distant metastasis. Oncol Rep 1994; 1: 1199-1201.
22. Tsubouchi H, Niitani Y, Hirono S, Nakayama H, Gohda E, Arakaki N, Sakiyama O, Takahashi K, Kimoto M, Kawakami S, Setogichi M, Tachikawa T, Shin S, Arima T, Daikuhara Y. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology 1991; 13: 1-5.
23. Weidner KM, Arakaki N, Hartmann G, Vanderkerckhove J, Weingart S, Rieder H, Fonatsch C, Tsubouchi H, Hishida T, Daikuhara Y, Birchmeier W. Evidence for the identify of human scatter factor and human hepatocyte growth factor. Proc Natl Acad Sci USA 1991; 88: 7001-7005.
24. Yamashita J, Ogawa M, Beppu T. Immunoreactive hepatocyte growth factor is present in tissue extracts from human breast cancer but not in conditioned medium of human breast cancer cell lines. Res Commun Chem Pathol Pharmacol 1993; 82: 249-252.
25. Yanagita K, Matsumoto K, Sekiguchi K, Ishibashi H, Niho Y, Nakamura T. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem 1993; 268: 21212-21217.
26. Yanagita K, Nagaike M, Ishibashi H, Niho Y, Matsumoto K, Nakamura T. Lung may have an endocrine function producing hepatocyte growth factor in response to injury of distal organs. Biochem Biophys Res Commun 1992; 182: 802-809.